| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c20782 _d20782 |
||
| 001 | BD-DhNSU-20782 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403064308.0 | ||
| 008 | 190403s2004 flua|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a1574911201 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRS200 _b.P425 2004 |
| 245 | 0 | 0 |
_aPharmaceutical preformulation and formulation : _ba practical guide from candidate drug selection to commercial dosage forn / _cedited by Mark Gibson |
| 260 |
_aBoca Raton : _bInterpharm/ CRC, _cc2004. |
||
| 300 |
_axi, 596 p. : _bill. ; _c26 cm. |
||
| 650 | 0 | _aDrugs | |
| 650 | 4 | _aDosage forms | |
| 650 | 4 | _aDrug | |
| 700 | 1 | _aGibson, Mark | |
| 942 |
_2lcc _cBK |
||